TAMOXIFEN MACULOPATHY

Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/23374

DC Field	Value	Language
dc.contributor.author	V. Cheleva Markovska	en_US
dc.date.accessioned	2022-10-12T08:48:14Z	-
dc.date.available	2022-10-12T08:48:14Z	-
dc.date.issued	2015	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/23374	-
dc.description.abstract	INTRODUCTION: One of the side effects of tamoxifen therapy is tamoxifen maculopathy. AIM: To describe clinical, angiographic and optical tomography feathers of tamoxifen maculopathy and to analyze bibliography review of previous studies. METHODS: Review of history, clinical examination, FFA and OCT findings of the images were conducted. RESULTS: Five patients with tamoxifen maculopathy, four of them with cellophane maculopathy with or without cystoid macular edema, one case with tamoxifen maculopathy in the eyes with sarcoidosis. CONCLUSION: Patients receiving tamoxifen should be monitored with OCT for funduscopicaly invisible changes in the inner retinal layers once a year.	en_US
dc.language.iso	en	en_US
dc.subject	Tamoxifen	en_US
dc.subject	maculopathy	en_US
dc.subject	medical maculopathy	en_US
dc.title	TAMOXIFEN MACULOPATHY	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	16 Congress of Serbian Ophthalmologists with international participation	en_US
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers